HealthEquity Inc. (HQY)

HealthEquity reported strong Q2 results with revenue and earnings beats, but valuation remains stretched, justifying a neutral-to-cautiously bullish rating. The company operates in a large, growing he...

HQY's Q2 results reflect EPS growth of 25.6% year over year, revenue growth of 8.6% and a 12% increase in HSA. The company also updates its fiscal 2026 guidance.

HealthEquity, Inc. (NASDAQ:HQY ) Q2 2026 Earnings Call September 2, 2025 4:30 PM EDT Company Participants Richard Putnam - Vice President of Investor Relations Scott Cutler - CEO, President & Director...

Although the revenue and EPS for HealthEquity (HQY) give a sense of how its business performed in the quarter ended July 2025, it might be worth considering how some key metrics compare with Wall Stre...

HealthEquity (HQY) came out with quarterly earnings of $1.08 per share, beating the Zacks Consensus Estimate of $0.92 per share. This compares to earnings of $0.86 per share a year ago.

HealthEquity, Inc. HQY released its second-quarter results after Tuesday's closing bell. Here's a look at the key figures from the quarter.

HealthEquity, Inc. HQY will release earnings results for the second quarter after the closing bell on Tuesday, Sept. 2.

HQY remains a buy for long-term investors, with exceptional economics, high margins, and capital-light growth despite recent multiple contraction. Q1 FY26 results showed strong revenue and earnings gr...

Investors interested in stocks from the Medical Services sector have probably already heard of CVS Health (CVS) and HealthEquity (HQY). But which of these two stocks presents investors with the better...

Get a deeper insight into the potential performance of HealthEquity (HQY) for the quarter ended July 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for so...